CellPort Software at the Process Development for Cell Therapies Conference

CellPort Software is excited to take part in the Process Development for Cell Therapies Summit in Boston, July 15–17, 2025. This leading industry event brings together experts working to improve cell therapy manufacturing processes, enhance scalability, and meet evolving regulatory standards. CellPort supports these goals with a purpose-built lab management system that helps teams reduce variability, strengthen traceability, and stay inspection-ready—so they can focus on delivering impactful therapies to patients.

Be sure to join our CEO's talk: "From Bench to Batch: Operational Readiness for ATMPs in the New Regulatory Era", where we’ll share practical insights for aligning your processes with EMA’s 2025 ATMP guidance and preparing for future FDA requirements.

Stop by our booth to see how CellPort helps you:

  • Achieve full traceability of cells, materials, equipment, and personnel
  • Automatically generate digital master batch records with time-stamped entries and e-signatures
  • Capture audit-ready data in a secure, compliant environment
  • Configure flexible workflows to support your evolving development programs

Let’s connect in Boston and explore how CellPort can help strengthen your process development and manufacturing efforts!

Categories
Subscribe to The CellPort Report

Get the latest updates, white papers, and CellPort news in our monthly newsletter – sign up today!